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open surgery for abdominal aortic aneurysms in low- to moderate-risk
patients
Jean-Pierre Becquemin, Jean-Chistophe Pillet, Franc¸ois Lescalie, Marc Sapoval,
Yann Goueffic, Patrick Lermusiaux, Eric Steinmetz, Jean Marzelle, for the ACE
trialists
Background: Several studies, including three randomized controlled trials
(RCTs), have shown that endovascular repair (EVAR) of abdominal aortic
aneurysms (AAA) offered better early results than open surgical repair
(OSR) but a similar medium-term to long-term mortality and a higher inci-
dence of reinterventions. Thus, the role of EVAR, most notably in low-risk
patients, remains debated.
Methods: The ACE (Anevrysme de l’aorte abdominale: Chirurgie versus
Endoprothese) trial compared mortality and major adverse events after
EVAR and OSR in patients with AAA anatomically suitable for EVAR and at
low-risk or intermediate-risk for open surgery. A total of 316 patients with
>5 cm aneurysms were randomized in institutions with proven expertise
for both treatments: 299 patients were available for analysis, and 149
were assigned to OSR and 150 to EVAR. Patients were monitored for 5 years
after treatment. Statistical analysis was by intention to treat.
Results: With a median follow-up of 3 years (range, 0-4.8 years), there was
no difference in the cumulative survival free of death or major events rates
between OSR and EVAR: 95.9%  1.6% vs 93.2%  2.1% at 1 year and 85.1% 
4.5% vs 82.4%  3.7% at 3 years, respectively (PZ .09). In-hospital mortality
(0.6% vs 1.3%; PZ 1.0), survival, and the percentage of minor complications
were not statistically different. In the EVAR group, however, the crude
percentage of reintervention was higher (2.4% vs 16%, P < .0001), with
a trend toward a higher aneurysm-related mortality (0.7% vs 4%; P Z .12).
Conclusions: In patients with low to intermediate risk factors, open repair of
AAA is as safe as EVAR and remains a more durable option.Repairing immediate proximal endoleaks during abdominal aortic
aneurysm repair
Ravi R. Rajani, Zachary M. Arthurs, Sunita D. Srivastava, Sean P. Lyden,
Daniel G. Clair, Matthew J. Eagleton
Introduction: Successful endovascular exclusion of abdominal aortic aneu-
rysms is largely dependent on adequate apposition of the stent graft to
the aortic wall. Proximal endoleaks at the time of stent graft placement
are uncommon but are more prevalent in patients with challenging neck
anatomy. If these initial leaks do not respond to simple balloon angioplasty,
Palmaz stents (Cordis Endovascular, Warren, NJ) and covered stent graft
cuffs both have been used to seal the endoleak. Long-term data regarding
the efficacy of one method over the other, however, is lacking.
Methods: We retrospectively reviewed a database of all infrarenal aortic
aneurysm repairs with an intraoperatively diagnosed type Ia endoleak
requiring Palmaz stent or covered stent graft cuff placement. Fenestrated
and branch grafts were excluded. All records and appropriate imaging* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(11)00158-4studies were reviewed. The primary end points were technical success of
aneurysm exclusion, recurrence of a type Ia leak, and need for
reintervention.
Results: At the time of the initial aneurysm repair, 72 patients required an
adjunctive covered extension or Palmaz stent; of these, 24 (33%) underwent
sole placement of a Palmaz stent, 45 (62.5%) underwent placement of
a covered stent graft cuff, and 3 required both a cuff and a Palmaz stent.
Aneurysmal exclusion was successful in all patients before leaving the oper-
ating room. No recurrent type Ia endoleak developed in patients who under-
went Palmaz stent placement. Of the 45 patients who underwent cuff
placement, proximal leaks developed in 3 that required reintervention: 1
was managed with a Palmaz stent and the other 2 required open surgical
revision.
Conclusions: Palmaz stent placement and stent graft cuff placement are
frequently used to seal immediate proximal endoleaks that do not resolve
with balloon angioplasty. Both methods appear to be durable long-term
options to facilitate endovascular exclusion of abdominal aortic aneurysms.
Increased prevalence of abdominal aortic aneurysm in patients undergoing
inguinal hernia repair compared with patients without hernia receiving
aneurysm screening
George A. Antoniou, Athanasios D. Giannoukas, George S. Georgiadis,
Stavros A. Antoniou, Constantinos Simopoulos, Panagiotis Prassopoulos,
Miltos K. Lazarides
Background: The introduction of screening programs for abdominal aortic
aneurysm (AAA) is being contemplated by health services in several coun-
tries. The correlation between aortic aneurysm and abdominal wall
hernias is well reported, and inguinal hernia has been identified as
a risk factor for aortic aneurysm. However, the prevalence of AAA in
patients with inguinal hernia has not been adequately documented. This
study evaluated whether patients with inguinal hernia are at increased
risk of having an AAA compared with patients without hernia receiving
aneurysm screening.
Methods: Men aged >55 undergoing primary inguinal hernia repair under-
went ultrasound imaging of the abdominal aorta to screen for aneurysm. A
reference group was selected from men without clinical evidence of inguinal
hernia participating in an AAA screening program. Prevalence and odds
ratios of AAA in the two groups were calculated.
Results: The study cohort comprised 235 patients with inguinal hernia and
203 controls. The mean  SD aortic diameter was 22  9 mm in patients
with inguinal hernia vs 20  6 mm for controls (P = .045). The prevalence
of AAA was 8.1% in the hernia group and 3.9% in the control group (adjusted
odds ratio, 3.9; 95% confidence interval, 1.6-9.5; P = .039). For aneurysms
>4 cm, the prevalence was 5.1% in those with an inguinal hernia and 1.5%
in those without an inguinal hernia (adjusted odds ratio, 4.7; 95% confidence
interval, 1.2-18.5, P = .025).
Conclusions: Inguinal hernia was a significant risk factor for AAA. Entry into
a screening program of men aged >55 admitted for inguinal hernia repair
should be considered.
712 AbstractsA multicenter experience of the management of collapsed thoracic
endografts
Rami O. Tadros, Evan C. Lipsitz, Rabih A. Chaer, Peter L. Faries, Michael L.
Marin, Jae-Sung Cho
Objectives: Thoracic endograft collapse after thoracic endovascular aortic
repair (TEVAR) is a potentially devastating complication. This study evalu-
ates the management of thoracic stent graft collapse.
Methods: A multicenter review of thoracic stent graft collapse was per-
formed from 2005 to 2009. Diagnosis and preoperative planning was per-
formed by computed tomography angiography (CTA). Outcome measures
included success of endovascular salvage, postoperative complications,
and conversion to open repair.
Results: Eleven patients (10 men) with thoracic endograft collapse were
identified. Mean age was 41.2 years old (range, 21-66 years). Indications
for the index TEVAR were traumatic aortic transections in 8 patients and
acute type B dissections in 3 patients. All were initially treated with the
TAG endoprosthesis (Gore and Associates, Flagstaff, Ariz). The median dura-
tion from initial repair to diagnosis of collapse was 9 days (range, 1 day-38
months). All collapses were initially treated by endovascular means using
another TAG device in 7 patients, a Talent (Medtronic, Santa Rosa, Calif)
thoracic stent graft in 3 patients, and a Palmaz (Cordis Endovascular,
Warren, NJ) stent in 1 patient. In 1 patient, the secondary TAG did not
resolve the collapse and required a Palmaz stent placement. Technical
success rate was 91%, while re-expansion of the collapsed endograft was
achieved in all patients. Early and late complications were observed in 3
patients. Delayed (>30 days) open conversion with device explantation
was performed for an aortoesophageal fistula, physiological aortic coarcta-
tion, and prevention of a recurrent collapse in 1 patient each. There were
no perioperative deaths or recurrent collapses.
Conclusion: Endograft collapse can be successfully managed by endovascu-
lar techniques in most cases. Redo-TEVAR using high radial force devices
should be considered the initial treatment of choice. Late endograft-related
complications after treatment of collapsed endografts are not uncommon
and can be safely managed by open conversion.Synchronous carotid artery stenting and open heart surgery
Ioannis Velissaris, Dimitrios Kiskinis, Kyriakos Anastasiadis
Background: The optimal management of the patients requiring cardiac
surgery with concomitant severe carotid disease remains a controversy.
The traditional approach involves staged or combined carotid endarterec-
tomy and cardiac surgery. This study evaluated the feasibility and safety
of angioplasty and stenting for the treatment of carotid stenoses concomi-
tantly to cardiac operations to reduce the risk of perioperative stroke.
Methods: All patients scheduled for cardiac surgery were screened preoper-
atively by color duplex ultrasonography for carotid disease. Carotid stenoses
60% in symptomatic patients and 70% in asymptomatic patients were
treated using carotid artery stenting (CAS) under local anesthesia immedi-
ately before the open heart surgery. Cerebral protection devices were
used in all cases. Patients did not receive aspirin or clopidogrel before the
procedure. In a prospective, nonrandomized study, we analyzed 90 consec-
utive patients requiring cardiac surgery with concomitant severe carotid
artery disease who underwent one stage CAS and cardiac surgery.
Results: Despite the high baseline risk profile, our results were encouraging.
Carotid stenting was successful in all patients. No neurologic complications
occurred during the carotid stenting procedures. The 30-day death/stroke
rate was 2.2% (one death, one contralateral stroke). No myocardial infarc-
tion occurred. The carotid restenosis rate was zero during the interme-
diate-term follow-up.
Conclusions: In our experience, CAS followed immediately by cardiac
surgery is safe and represents a reasonable option for selected patients pre-
senting with severe carotid and coronary disease.Upper- versus lower-limb aerobic exercise training on health-related
quality of life in patients with symptomatic peripheral arterial disease
John M. Saxton, Irena Zwierska, Milisa Blagojevic, Sohail A. Choksy, Shah
Nawaz, A. Graham Pockley
Objective: This randomized controlled trial investigated the effects of
upper- and lower-limb aerobic exercise training on disease-specificfunctional status and generic health-related quality of life (QOL) in patients
with intermittent claudication.
Methods: The study recruited 104 patients (mean age, 68 years; range, 50-
85) from the Sheffield Vascular Institute. Patients were randomly allocated
to groups that received upper-limb (ULG) or lower-limb (LLG) aerobic exer-
cise training, or to a nonexercise control group. Exercise was performed
twice weekly for 24 weeks at equivalent limb-specific relative exercise
intensities. Main outcome measures were scores on the Walking Impairment
Questionnaire (WIQ) for disease-specific functional status, the Medical
Outcomes Study Short Form version 2 (SF-36v2), and European Quality of
Life Visual Analog Scale (EQ-VAS) for health-related QOL. Outcomes were
assessed at baseline, and at 6, 24, 48, and 72 weeks.
Results: After 6 weeks, improvements in the perceived severity of claudica-
tion (P = .023) and stair climbing ability (P = .011) vs controls were observed
in the ULG, and an improvement in the general health domain of the SF-36v2
vs controls was observed in the LLG (P = .010). After 24 weeks, all four WIQ
domains were improved in the ULG vs controls (P  .05), and three of the
four WIQ domains were improved in the LLG (P < .05). After 24 to 72 weeks
of follow-up, more consistent changes in generic health-related QOL
domains were apparent in the ULG.
Conclusions: These findings support the use of alternative, relatively pain-
free forms of exercise in the clinical management of patients with intermit-
tent claudication.Creation of wrist ulnar-basilic autogenous arteriovenous access for
hemodialysis in adults and children using microsurgery
Pierre Bourquelot, Olivier Van-Laere, Georges Baaklini, Luc Turmel-
Rodrigues, Gilbert Franco, Julien Gaudric, Alain Raynaud
Objectives: The distal basilic forearm vein is frequently preserved and
might be used more frequently for creation of an ulnar-basilic autogenous
arteriovenous access (UB-AAVA) in the wrist despite the small size of the
two vessels. The scarcity of publications led us to initiate a prospective
study regarding the creation and outcomes of UB-AAVAs.
Methods: Seventy patients (63 adults, seven children) with no usable
cephalic vein in either forearm were selected consecutively over 4 years
for creation of a UB-AAVA. The prerequisite was a clinically visible or
palpable forearm basilic vein after placing a tourniquet. Regional anes-
thesia, prophylactic hemostasis, and a surgical microscope were used
systematically. Secondary superficialization was performed in two patients.
Most non-matured accesses were abandoned in favor of the creation of
a more proximal autogenous access. Mean follow-up was 20 months (SD =15).
Results: Immediate patency was obtained in 94% of adults and 100% of chil-
dren. Success (in-use access) was achieved in 60% of patients (38/63 adults
and 6/7 children) after a mean postoperative interval of 80 days (SD = 64;
range, 31-277). Failures included four immediate thromboses, one postoper-
ative death, and 21 never-matured accesses. No steal syndrome was
observed. Initial failures included, primary patency rates in adults at 1
and 2 years were 42%  6% and 30%  7%, respectively; secondary patency
rates at 1 year and 2 years were 60%  6% and 53%  7%, respectively.
Conclusions: Although patency rates are not as good as those achieved with
radial cephalic-AAVA, the UB-AAVA is an alternative autogenous forearm
access before the creation of any other access involving the basilic vein.
The use of the surgical microscope is mandatory, and more than usual
time is required to achieve maturation.The utility of screening for deep venous thrombosis in asymptomatic,
non-ambulatory neurosurgical patients
Meghan Dermody, Jean Alessi-Chinetti, Mark D. Iafrati, James M. Estes
Objectives: Decisions regarding deep venous thrombosis (DVT) prophylaxis
are complicated in neurosurgical patients because of the potential for cata-
strophic bleeding complications. Screening with venous duplex ultrasound
(VDUS) may improve outcomes, but can strain hospital resources. Since
there is little data to guide VDUS surveillance, we investigated the utility
of a comprehensive VDUS screening program in neurosurgical patients.
Methods: Medical records of patients admitted to the neurosurgical service
at a university-affiliated hospital from October 2007 through January 2010
who underwent weekly VDUS of the lower extremities until ambulatory or
discharged were retrospectively reviewed. Demographics, comorbidities,
interventions, and use of DVT prophylaxis were recorded. All patients in
Abstracts 713this study were asymptomatic for clinical evidence of DVT. When DVT was
identified, VDUS reported its location and progression.
Results: One hundred seventy-four consecutive patients were screened
according to the established protocol. They had 312 VDUS studies, 68
(21.8%) of which were positive in 40 (23%) unique patients; 10 were bilateral
and two catheter-related. There were no documented pulmonary emboli in
this series. Seventeen patients (37.7%) had isolated calf DVT, four of which
were bilateral (totaling 21 thrombi), and 9 (20%) had coexistent thrombi in
calf and proximal veins. Of the 21 isolated calf DVTs, 15 had follow-up
studies and two progressed to the popliteal or ileofemoral vein on follow-
up (13.3%). Mechanical prophylaxis was uniformly utilized, but chemical
prophylaxis varied based on surgeons’ assessment of bleeding risk. DVT
developed in 19.3% (28/145) of patients receiving prophylactic medication(unfractionated heparin or low-molecular weight heparin) and 41.4% (12/
29) receiving no chemoprophylaxis (P < .001). The only patient character-
istic that correlated with DVT risk was a body mass index <0 (9.1% vs
29.4%, P Z .01).
Conclusions: Despite the uniform application of mechanical DVT prophylaxis
and the use of chemoprophylaxis in a majority of patients, we found a 23%
incidence of DVT in these hospitalized, nonambulatory, neurosurgical
patients. No patients with isolated calf DVT had an embolic complication
but 13.3% progressed proximally in short-term follow-up. While chemical
prophylaxis significantly reduced DVT risk, no factor was sufficiently predic-
tive to exclude patients from screening. These data substantiate the impor-
tance of full leg VDUS screening and maximizing DVT prophylaxis in this high
risk population.
